SEC 13F Intelligence

Kingfisher Capital LLC / ABT

Kingfisher Capital LLC’s Abbott Laboratories Position

Does Kingfisher Capital LLC own Abbott Laboratories (ABT)? Yes41.0K shares worth $5M (+1.07% of its 13F portfolio) as of Q3 2024, down from 44.1K shares the prior filed quarter.

Position Value
$5M
Q3 2024
Shares
41.0K
% of Portfolio
+1.07%
Quarters Held
24
currently held

Position History ABT

Reported value by quarter
Q4 ’18: $3MQ4 ’18Q1 ’19: $3MQ2 ’19: $3MQ3 ’19: $3MQ3 ’19Q4 ’19: $3MQ1 ’20: $3MQ2 ’20: $3MQ2 ’20Q3 ’20: $4MQ4 ’20: $4MQ1 ’21: $5MQ1 ’21Q2 ’21: $5MQ3 ’21: $5MQ4 ’21: $7MQ4 ’21Q1 ’22: $6MQ2 ’22: $6MQ3 ’22: $5MQ3 ’22Q4 ’22: $7MQ1 ’23: $7MQ2 ’23: $7MQ2 ’23Q3 ’23: $6MQ4 ’23: $5MQ1 ’24: $5MQ1 ’24Q2 ’24: $5MQ3 ’24: $5Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 202441.0K$5M+1.07%
Q2 202444.1K$5M+1.07%
Q1 202444.5K$5M+1.22%
Q4 202347.5K$5M+1.36%
Q3 202366.1K$6M+1.74%
Q2 202365.6K$7M+1.86%
Q1 202366.7K$7M+1.77%
Q4 202266.4K$7M+1.94%
Q3 202256.1K$5M+1.50%
Q2 202252.1K$6M+1.62%
Q1 202249.0K$6M+1.50%
Q4 202148.2K$7M+1.57%
Q3 202145.1K$5M+1.38%
Q2 202143.8K$5M+1.29%
Q1 202142.1K$5M+1.41%
Q4 202039.8K$4M+1.32%
Q3 202036.9K$4M+1.44%
Q2 202035.2K$3M+1.43%
Q1 202034.8K$3M+1.41%
Q4 201935.5K$3M+1.44%
Q3 201935.1K$3M+1.75%
Q2 201935.0K$3M+1.82%
Q1 201935.9K$3M+1.84%
Q4 201837.3K$3M+1.92%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Kingfisher Capital LLC’s full portfolio or all institutional holders of ABT.